Scientists developed a novel weight-loss drug described as a Trojan horse that sneaks metabolic-boosting compounds into cells.
Early studies reported striking results beyond those seen with existing GLP-1 therapies.
The design delivers extra metabolic power directly inside cells rather than acting only through appetite or insulin pathways.
GLP-1 drugs have dominated recent weight-management treatment but do not work equally for all patients.
Researchers engineered the compound to bypass cellular defenses that normally block foreign molecules.
Laboratory and early human data suggested enhanced fat metabolism compared with standard approaches.
Investigators said the Trojan horse mechanism targets energy use at the cellular level.
Regulatory approval would require extensive safety and efficacy testing in larger trials.
The drug’s performance relative to GLP-1 medications remains under active study.
Analysts noted that new metabolic agents could expand options for people who do not respond to current drugs.
Created by Ayen Stabel.
Stabel is AI and can make mistakes.
Sources:
https://scitechdaily.com/